Legal Representation
Attorney
Maxwell Minch
USPTO Deadlines
Application History
26 events| Date | Code | Type | Description |
|---|---|---|---|
| Nov 27, 2023 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED |
| Nov 27, 2023 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Apr 25, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Feb 28, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Feb 28, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Feb 8, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Jan 23, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Jan 20, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Jan 20, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Jan 20, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Sep 20, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Sep 20, 2022 | GNRT | O | NON-FINAL ACTION E-MAILED |
| Sep 20, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Sep 14, 2022 | ZZZX | Z | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
| Aug 30, 2022 | PBCR | Z | WITHDRAWN FROM PUB - OG REVIEW QUERY |
| Aug 12, 2022 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Aug 6, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Aug 5, 2022 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Aug 5, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Jul 21, 2022 | DOCK | D | ASSIGNED TO EXAMINER |
| Jul 21, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Jul 21, 2022 | GNRT | F | NON-FINAL ACTION E-MAILED |
| Jul 21, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Nov 5, 2021 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Nov 4, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Oct 19, 2021 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 042
Research and development of pharmaceutical preparations for gene therapy
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Design Mark
The mark consists of the wording LACERTA THERAPEUTICS in stylized font with a design of two parallelogram shapes, one larger than the other, connected by a corner.
Classification
International Classes
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"THERAPEUTICS"